Summit Global Investments Ani Pharmaceuticals Inc Transaction History
Summit Global Investments
- $1.34 Billion
- Q1 2024
A detailed history of Summit Global Investments transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Summit Global Investments holds 15,142 shares of ANIP stock, worth $964,242. This represents 0.08% of its overall portfolio holdings.
Number of Shares
15,142
Previous 14,027
7.95%
Holding current value
$964,242
Previous $773,000
35.45%
% of portfolio
0.08%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding ANIP
# of Institutions
206Shares Held
14MCall Options Held
26.7KPut Options Held
237K-
Black Rock Inc. New York, NY2.53MShares$161 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$83.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY959KShares$61 Million2.26% of portfolio
-
Deep Track Capital, LP Greenwich, CT822KShares$52.3 Million1.88% of portfolio
-
Dimensional Fund Advisors LP Austin, TX609KShares$38.8 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.11B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...